Brief: Inozyme Pharma Reports Third Quarter 2021 Financial Results And Provides Business Highlights
09/11/2021 22:18
Nov 9 (Reuters) - Inozyme Pharma Inc INZY.O :
* INOZYME PHARMA REPORTS THIRD QUARTER 2021 FINANCIAL
RESULTS AND
PROVIDES BUSINESS HIGHLIGHTS
* INOZYME PHARMA INC- QTRLY LOSS PER SHARE $0.60
Source text for Eikon: ID:nGNX7rKmlb
Further company coverage: INZY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Inozyme Pharma
See all newsBrief: Inozyme Pharma postpones 2025 annual meeting of stockholders
U.S. RESEARCH ROUNDUP-Advansix, Cognizant, Inozyme Pharma
U.S. STOCKS ON THE MOVE-Netflix, Acadia Pharma, CoreWeave
U.S. STOCKS ON THE MOVE-Inozyme Pharma, Emerson Electric, Stanley Black & Decker
Inozyme Pharma rises over 175% on $270 million buyout deal with BioMarin